AzTrials
AzTrials

Condition

Opioid Use Clinical Trials

Studies of opioid use, matched by condition name and medical subject headings. Start with those open to enrolment.

1,886 registered studies

In numbers

Open to volunteers
410
Active
505
With results posted
439
All registered
1,886

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 410
  • Opioid Use Disorder, Alcohol Intoxication

    Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder

    • Not yet recruiting
    • Age: 21 to 65 years
    • Early Phase 1

    The goal of this clinical trial is to examine whether individuals with co-occurring opioid use disorder and alcohol use (OUD+ALC) experience heightened pain sensitivity, pain-related negative affect, and greater alcohol…

    Conditions
    Opioid Use Disorder, Alcohol Intoxication, Pain
    Trial name
    NCT07894276
    Testing
    Alcohol
    Where
    United States
    Volunteers
    90 people
    Sponsor
    Ohio State University
    Can I take part? NCT07894276
  • Pain, Postoperative

    Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

    • Recruiting
    • Age: Up to 17 years
    • Phase 2/3

    The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery.

    Trial name
    NCT04724252
    Testing
    Gabapentin
    Where
    United States
    Volunteers
    60 people
    Sponsor
    University of California, Davis
    Can I take part? NCT04724252
  • Substance Use Disorders (SUDs)

    Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

    • Enrolling by invitation
    • Age: 18 to 99 years
    • Observational study

    Background: A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses. Different versions of the tool are used to track the use of alcohol, cigarettes, and cannabis.

    Trial name
    NCT06995885
    Where
    United States
    Volunteers
    30 people
    Sponsor
    National Institute on Drug Abuse (NIDA)
    Can I take part? NCT06995885
  • Opioid-Related Disorders, Drug Addiction

    Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

    • Recruiting
    • Age: 21 to 60 years
    • Observational study

    Background: People with addictions often find it hard to choose the long-term benefits of abstinence over the short-term effects of using drugs.

    Trial name
    NCT03745339
    Where
    United States
    Volunteers
    150 people, healthy volunteers welcome
    Sponsor
    National Institute on Drug Abuse (NIDA)
    Can I take part? NCT03745339
  • Chronic Pain, Pain

    A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain

    • Recruiting
    • Age: 18 to 65 years
    • Phase 2

    This Phase 2 study will evaluate whether multiple doses of cebranopadol suppress opioid withdrawal signs and symptoms compared with placebo in adults with chronic pain who are physically dependent on prescribed opioids.

    Conditions
    Chronic Pain, Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder
    Trial name
    NCT07874620
    Testing
    Cebranopadol
    Where
    2 sites in United States
    Volunteers
    45 people
    Sponsor
    Adneuris Therapeutics, Inc.
    Can I take part? NCT07874620
  • Alcohol Use, Cannabis Use

    MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education

    • Recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The MATAspire intervention is a web-app designed to promote substance misuse prevention education and bolster protective coping skills whereby students complete six weekly interactive modules using a smart device or computer.

    Conditions
    Alcohol Use, Cannabis Use, Nicotine Use, Illicit Drug Use
    Trial name
    MATAspire (NCT06553196)
    Testing
    MATAspire Web-app
    Where
    United States
    Volunteers
    1,000 people, healthy volunteers welcome
    Sponsor
    California State University, Northridge
    Can I take part? MATAspire
  • Burnout, Secondary Trauma

    PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)

    • Enrolling by invitation
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The investigators propose to test the effectiveness of PATH (Peer Advanced Training for total Health) as an educational workforce intervention for improving peer recovery support specialists' (PRSS) overdose prevention (OP)…

    Conditions
    Burnout, Secondary Trauma, Compassion Fatigue, Opioid Use Disorder
    Trial name
    NCT07886944
    Testing
    PATH (Peer Advanced Training for total Health)
    Where
    United States
    Volunteers
    200 people
    Sponsor
    Chestnut Health Systems
    Can I take part? NCT07886944
  • Chronic Pain, Opioid Use Disorder

    Cannabidiol in Opioid Use Disorder and Chronic Pain With Buprenorphine

    • Recruiting
    • Age: 18 to 70 years
    • Early Phase 1
    • Pill or oral medicine

    This is a randomized, placebo-controlled, crossover human laboratory study investigating the dose-dependent safety and acute effects of Cannabidiol (CBD) on measures of pain and opioid craving in outpatients with opioid use…

    Trial name
    NCT07886606
    Testing
    400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol
    Where
    United States
    Volunteers
    34 people
    Sponsor
    Yale University
    Can I take part? NCT07886606
  • Mild Cognitive Impairment (MCI), Opioid Use

    Postsurgical Pain and Opioid Use in Older Adults: Effects of Mild Cognitive Impairment

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    Mild cognitive impairment (MCI) affects a substantial proportion of older adults undergoing major surgery and may alter pain processing, pain experience, and opioid use after surgery.

    Conditions
    Mild Cognitive Impairment (MCI), Opioid Use, Cognitive Dysfunction, Postoperative Pain
    Trial name
    NCT07885085
    Where
    United States
    Volunteers
    552 people
    Sponsor
    Miklos Kertai
    Can I take part? NCT07885085
  • Opioid Use Disorder

    Ketamine for Opioid Use Disorder

    • Recruiting
    • Age: 18 to 65 years
    • Phase 2

    The goal of this clinical trial is to learn if ketamine works to reduce craving for opioids in adults enrolled in methadone treatment for opioid use disorder.

    Trial name
    NCT06943859
    Testing
    Treatment with Ketamine, Treatment with Very Low Dose Ketamine
    Where
    United States
    Volunteers
    50 people
    Sponsor
    University of Maryland, Baltimore
    Can I take part? NCT06943859

Completed, with results posted

All 369
  • Opioid-Related Disorders, NAS

    MOms in REcovery (MORE) Study: Defining Optimal Care

    • Completed
    • Age: 16 to 50 years
    • Observational study
    • Results posted

    Northern New England has among the highest rates of opioid dependence in the U.S. This region also has among the highest rates of opioid-related deaths in the U.S., with a disproportionate high rate among pregnant women with…

    Conditions
    Opioid-Related Disorders, NAS, Substance Use Disorders, Mental Health
    Trial name
    MORE (NCT04251208)
    Testing
    Observational Study
    Where
    10 sites in United States
    Volunteers
    2,510 people
    Sponsor
    Trustees of Dartmouth College
    Can I take part? MORE
  • Telehealth at the Library, Control Group

    "Bupe by the Book": Testing Library Telehealth With Unstably Housed Persons With Opioid Use Disorder

    • Completed
    • Age: 18 years and older
    • Lifestyle or therapy programme
    • Results posted

    Public libraries nationwide are facing an on-premise opioid overdose crisis. Many persons with opioid use disorder (OUD) remained unhoused and profoundly hard to reach.

    Trial name
    BBB (NCT05872386)
    Testing
    Library Telehealth with Buprenorphine Provider, Treatment-as-Usual Control group
    Where
    United States
    Volunteers
    60 people, healthy volunteers welcome
    Sponsor
    University of California, San Diego
    Can I take part? BBB
  • Opioid Use Disorder, Substance Use Disorder

    Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction

    • Completed
    • Age: 18 to 64 years
    • Lifestyle or therapy programme
    • Results posted

    Support groups are an important component of addiction treatment, where individuals at more stable stages of their recovery help others by sharing personal experiences.

    Conditions
    Opioid Use Disorder, Substance Use Disorder, Heroin Use Disorder
    Trial name
    NCT07344233
    Testing
    Real-time fMRI Neurofeedback
    Where
    United States
    Volunteers
    28 people
    Sponsor
    Icahn School of Medicine at Mount Sinai
    Can I take part? NCT07344233
  • Electronic Cigarette Use

    Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The goal of this study is to conduct a pilot randomized waitlist-controlled trial to assess the feasibility, acceptability, and preliminary effects of substituting the NIDA standardized research e-cigarette (SREC) for combusted…

    Trial name
    SWITCHED (NCT05881304)
    Testing
    Standardized research e-cigarette (SREC)
    Where
    United States
    Volunteers
    41 people, healthy volunteers welcome
    Sponsor
    Massachusetts General Hospital
    Can I take part? SWITCHED
  • Hepatitis C, Opioid-Related Disorders

    The Kentucky Viral Hepatitis Treatment Study

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Results posted

    The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is in the midst of the…

    Conditions
    Hepatitis C, Opioid-Related Disorders, Injection Drug Use
    Trial name
    KeY Treat (NCT03949764)
    Testing
    Sofosbuvir/velpatasvir (Epclusa®)
    Where
    United States
    Volunteers
    380 people
    Sponsor
    Jennifer Havens
    Can I take part? KeY Treat

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in